A One-Day, Single-Dose Treatment for Uncomplicated
Urinary Tract Infection in Women
INDICATIONS AND USAGE
MONUROL (fosfomycin tromethamine) is indicated only for the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of Escherichia coli and Enterococcus faecalis.
MONUROL is not indicated for the treatment of pyelonephritis or perinephric abscess. If persistence or reappearance of bacteriuria occurs after treatment with MONUROL, other therapeutic agents should be selected.
IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS
MONUROL is contraindicated in patients with known hypersensitivity to the drug.
A One-Day, Single-Dose Treatment for Uncomplicated
Urinary Tract Infection in Women
A One-Day, Single-Dose Treatment for Uncomplicated
Urinary Tract Infection in Women
With a well-studied clinical efficacy and safety profile, MONUROL® (fosfomycin tromethamine) granules for oral solution is the only single-dose oral antibiotic for uncomplicated urinary tract infection (UTI) in women. MONUROL® has more than 18 years of market experience and is an established treatment option for acute cystitis in women due to susceptible strains of E. coli and E. faecalis. | |
Product Overview | |
![]() |
Review MONUROL®, an IDSA recommended treatment option for acute uncomplicated cystitis in women. |
Microbiology & MOA | |
Escherichia coli |
Learn more about the antimicrobial spectrum and the mechanism of action of MONUROL®. |
Clinical Efficacy & Tolerability Profile | |
![]() |
Single-dose MONUROL® was studied against multi-day regimens of 3 comparator antibiotics. Review key clinical study data. |
Ellen: A Hypothetical Patient Profile | |
![]() |
Ellen, a 28-year-old patient, visits her PCP complaining of burning pain when urinating and increased urinary frequency over the last 24-48 hours. See her patient history, review of systems/exam, diagnosis, and treatment plan.
|